Hattie Hayes

The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen

The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March

Three leaders in glaucoma research, retina care and refractive surgery share their expertise

Antonio Filipe Macedo, OD, MSc, PhD, speaks about his ARVO presentation on vision-related activity difficulties in patients with neovascular age-related macular degeneration

New research findings presented at this year's ARVO meeting compare two groups of paediatric patients in Nepal

Susana Chung, OD, PhD, speaks about one of her ARVO presentations and the future of artificial intelligence in eye care

At this year's ARVO meeting, new data from the BLINK2 study show axial growth rates after discontinuing soft multifocal contact lens wear

Age of vision loss onset has a stark impact on patients’ auditory processing and sensory substitution

Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President

The tissue serves as a testing ground for outpatient ocular therapies

David Lubeck, MD, talks about the biggest surprises from ASCRS in the glaucoma space

The 15th annual Congress on Controversies in Ophthalmology heads to Athens, Greece

Josefina Botta, MD, MSc, discusses her real-world experiences with the RayOne EMV toric lens

Lohith Shetty will lead marketing for the company, based in Kleinostheim, Germany

The technology, which creates a 360-degree, instantaneous capsulotomy, appeared at the Eyecelerator event

Dr Nir Shoham-Hazon presented two papers detailing outcomes from the iTrack microcatheter at ASCRS in Boston

Elizabeth Yeu, MD, discusses a corneal case report at ASCRS 2024

At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT

At this year's ASCRS meeting, J. Morgan Micheletti, MD, talks about his research and the Young Eye Surgeons (YES) programme

William F. Wiley, MD, shares key takeaways from his presentation on binocularity and stereoacuity

Dr Neda Nikpoor discusses Light Adjustable Lenses and the implications for clinicians at ASCRS 2024

At ASCRS 2024, Aurion Biotech's Global VP Eris Jordan previews upcoming clinical data from North America and Asia

Jascha Wendelstein, MD, discusses the outcomes of a study comparing K and TK measurements

At ASCRS 2024, Oliver Findl, MD, provides an update on the ESCRS IOL calculator and new tools to come this year

Ahead of the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment

At the 2024 ASCRS meeting, Anthony Wallace details the presentations and educational programmes from Bausch + Lomb

At the ASCRS meeting in Boston, Dan Tran, MD, details his presentation on incision quality and clinical outcomes of femtosecond laser

At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma

Adam Muzychuk, MD, BSc, FRCSC, discusses his ASCRS 2024 presentation on toric lens use for patients with low astigmatism

Greg Kunst, CEO of Aurion Biotech, discusses AURN001, a novel cell therapy targeting corneal endothelial disease